Amgen Inc. today announced results from its first Phase 1/2 study evaluating the safety and efficacy of Nplate® (romiplostim) in children with chronic immune thrombocytopenic purpura (ITP).
See the article here:
Amgen announces results from first Phase 1/2 study of Nplate (News-Medical-Net)
Ninety percent of all vaccine preventable deaths occur in those 65 and older, including residents in nursing homes, according to highlighted studies in the Pennsylvania Patient Safety Authority’s 2009 December Patient Safety Advisory.
Visit link:
Study reveals that majority of all vaccine preventable deaths occur in those 65 and older (News-Medical-Net)
No treatment of affected animals. Measures to be applied. No other measures. Diagnostic test results. Laboratory name and type Finnish Food Safety Authority (National laboratory). Tests and results: Species – Test – Test date – Result …
See more here:
A TIME'S MEMORY: Pandemic influenza A/H1N1 2009, Finland (WAHID …
Thanks to hard work by Columbia’s Vice President of Safety and Security Robert Koverman, I received my H1N1 vaccine on Oct. 21. I am one of a small but lucky group of people who were able to get the vaccine. But soon, despite the outcry by health care professionals about continued shortage around the country,
See the rest here:
Editor’s note (The Columbia Chronicle)
Due to the heightened level of H1N1 influenza activity in the region, Mercy Hospital Grayling is temporarily restricting its visitor policy for the safety of its patients and staff.
Read the original here:
Visitation restrictions put in place at hospital due to H1N1 (Crawford County Avalanche)
FOSTER CITY, CA–(Marketwire – 10/21/09) – SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN – News ) today announced the enrollment of its first patient at the Atlanta Gastroenterology Associates in Atlanta, GA, in a phase 2 trial of SCV-07 for the treatment of hepatitis C (also known as HCV). This multicenter, multidose, open-label study is designed to evaluate the safety and immunomodulatory …
DOCTORS in Bahrain are in two minds over the safety of the swine flu vaccine, with some saying they would think twice about taking it themselves.
Read more from the original source:
Doctors wary over safety of H1N1 jabs (Gulf Daily News)
DOHA: Pacifying the tensions on the safety of H1N1 vaccines, which will be given to people here once available, experts say that the on going test trails being conducted are just to remove fear. Rumours have been going on that the vaccines lack the necessary examination to be administered.
Continue reading here:
Official allays fears about flu vaccine (The Peninsula)